APH-1902

N/A

Report date: 2023/01/08 10:16:24
NME

Base Information

Drug NameAPH-1902
Drug Alias NameAPH1902
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRejection of renal transplantationRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAphios Corporation
China Registration ClassN/A

Develop Information

Active CompaniesAphios Corporation
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationRejection of liver transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A